Pharmacokinetics and toxicity of an yttrium-90-citc-dtpa-hmfg1 radioimmunoconjugate for intraperitoneal radioimmunotherapy of ovarian cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (16)
Peripheral Neuropathy
1985 • 276 citations
Radionuclide selection and model absorbed dose calculations for radiolabeled tumor associated antibodies
1984 • 259 citations
Antibodies against metal chelates
1985 • 253 citations
Cancer Statistics, 1987
1987 • 241 citations
Antibody-guided irradiation of advanced ovarian cancer with intraperitoneally administered radiolabeled monoclonal antibodies.
1987 • 205 citations
Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody
1993 • 171 citations
Specific IgE antibodies to platinum salts in sensitized workers
1979 • 168 citations
The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex
1988 • 167 citations
Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01.
1991 • 123 citations
Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer.
1990 • 122 citations
The curability of tumours of differing size by targeted radiotherapy using 131I or 90Y
1991 • 105 citations
Antibodies elicited against cis-diamminedichloroplatinum(II)-modified DNA are specific for cis-diamminedichloroplatinum(II)-DNA adducts formed in vivo and in vitro.
1982 • 98 citations
Monoclonal antibodies : applications in clinical oncology
1991 • 69 citations
Radiocolloids in the Treatment of Ovarian Cancer
1979 • 63 citations
Intraperitoneal recombinant alpha-2-interferon alternating with cisplatin as salvage therapy for minimal residual-disease ovarian cancer: a phase II study.
1990 • 61 citations
Selection of reagents for human radioimmunotherapy
1992 • 34 citations